Stable ubiquitination of human T-cell leukemia virus type 1 tax is required for proteasome binding

Journal of Virology

Volumn 78, Issue 21, 2004, Pages 11823-11832

  Chiari, Estelle ^a   Lamsoul, Isabelle ^b   Lodewick, Julie ^b   Chopin, Cécile ^a   Bex, Françoise ^b   Pique, Claudine ^a  

^a CNRS   (France)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONJUGATION; CONTROLLED STUDY; ENZYME BINDING; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN TARGETING; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UBIQUITINATION;

EID: 6344229847     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.21.11823-11832.2004     Document Type: Article

References (41)

1. Alefantis, T., K. Barmak, E. W. Harhaj, C. Grant, and B. Wigdahl. 2003. Characterization of a nuclear export signal within the human T-cell leukemia virus type I transactivator protein Tax. J. Biol. Chem. 278:21814-21822.
2. Astier-Gin, T., J. P. Portail, F. Lafond, and B. Guillemain. 1995. Identification of HTLV-1- or HTLV-1I-producing cells by cocultivation with BHK-21 cells stably transfected with a long terminal repeat-lacZ gene construct. J. Virol. Methods 51:19-29.
3. Beraud, C., and W. C. Greene. 1996. Interaction of HTLV-1 Tax with the human proteasome: implications for NF-kappa B induction. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1):S76-S84.
4. Bex, F., and R. B. Gaynor. 1998. Regulation of gene expression by HTLV-1 Tax protein. Methods 16:83-94.
5. Bex, F., K. Murphy, R. Wattiez, A. Burny, and R. B. Gaynor. 1999. Phosphorylation of the human T-cell leukemia virus type 1 transactivator tax on adjacent serine residues is critical for tax activation. J. Virol. 73:738-745.
6. Bhat, N. K., Y. Adachi, K. P. Samuel, and D. Derse. 1993. HTLV-1 gene expression by defective proviruses in an infected T-cell line. Virology 196: 15-24.
7. Bieganowska, K., P. Hollsberg, G. J. Buckle, D. G. Lim, T. F. Greten, J. Schneck, J. D. Altman, S. Jacobson, S. L. Ledis, B. Hanchard, J. Chin, O. Morgan, P. A. Roth, and D. A. Hafler. 1999. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T-cell lymphotropic virus-associated myelopathy. J. Immunol. 162:1765-1771.
8. Bres, V., R. E. Kiernan, L. K. Linares, C. Chable-Bessia, O. Plechakova, C. Treand, S. Emiliani, J. M. Peloponese, K. T. Jeang, O. Coax, M. Scheffner, and M. Benkirane. 2003. A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nat. Cell Biol. 5:754-761.
9. Brooks, P., G. Fuertes, R. Z. Murray, S. Bose, E. Knecht, M. C. Rechsteiner, K. B. Hendil, K. Tanaka, J. Dyson, and J. Rivett. 2000. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem. J. 346:155-161.
10. Ciechanover, A., and R. Ben-Saadon. 2004. N-terminal ubiquitination: more protein substrates join in. Trends Cell Biol. 14:103-106.
11. Ecker, D. J., J. M. Stadel, T. R. Butt, J. A. Marsh, B. P. Monia, D. A. Powers, J. A. German, P. E. Clark, F. Warren, A. Shatzman, et al. 1989. Increasing gene expression in yeast by fusion to ubiquitin. J. Biol. Chem. 264:7715-7719.
12. Ferdous, A., F. Gonzalez, L. Sun, T. Kodadek, and S. A. Johnston. 2001. The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol. Cell 7:981-991.
13. Gatza, M. L., J. C. Watt, and S. J. Marriott. 2003. Cellular transformation by the HTLV-1 Tax protein, a jack-of-all-trades. Oncogene 22:5141-5149.
14. Gonzalez, F., A. Delahodde, T. Kodadek, and S. A. Johnston. 2002. Recruitment of a 19S proteasome subcomplex to an activated promoter. Science 296:548-550.
15. Grant, C., K. Barmak, T. Alefantis, J. Yao, S. Jacobson, and B. Wigdahl. 2002. Human T-cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J. Cell Physiol. 190:133-159.
16. Hanon, E., S. Hall, G. P. Taylor, M. Saito, R. Davis, Y. Tanaka, K. Usuku, M. Osame, J. N. Weber, and C. R. Bangham. 2000. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-1) is prevented by cytotoxic T lymphocytes. Blood 95:1386-1392.
17. Hemelaar, J., F. Bex, B. Booth, V. Cerundolo, A. McMichael, and S. Daenke. 2001. Human T-cell leukemia virus type 1 Tax protein binds to assembled nuclear proteasomes and enhances their proteolytic activity. J. Virol. 75: 11106-11115.
18. Hendil, K. B., P. Kristensen, and W. Uerkvitz. 1995. Hum. proteasomes analysed with monoclonal antibodies. Biochem. J. 305:245-252.
19. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425-479.
20. Hu, Z., Z. Zhang, E. Doo, O. Coux, A. L. Goldberg, and T. J. Liang. 1999. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J. Virol. 73:7231-7240.
21. Jeang, K. T. 2001. Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-kappa B. Cytokine Growth Factor Rev. 12:207-217.
22. Kannagi, M., S. Harada, I. Maruyama, H. Inoko, H. Igarashi, G. Kuwashima, S. Sato, M. Morita, M. Kidokoro, M. Sugimoto, and et al. 1991. Predominant recognition of human T-cell leukemia virus type I (HTLV-1) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-1-infected cells. Int. Immunol. 3:761-767.
23. Kubota, R., T. Kawanishi, H. Matsubara, A. Manns, and S. Jacobson. 2000. HTLV-1 specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals. J. Neuroimmunol. 102:208-215.
24. Leiten, V., P. Agre, and L. S. King. 2001. Altered ubiquitination and stability of aquaporin-1 in hypertonic stress. Proc. Natl. Acad. Sci. USA 98:2894-2898.
25. Levin, M. C., S. M. Lee, F. Kalume, Y. Morcos, F. C. Dohan, Jr., K. A. Hasty, J. C. Callaway, J. Zunt, D. Desiderio, and J. M. Stuart. 2002. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat. Med. 8:509-513.
26. Lomas, M., E. Hanon, Y. Tanaka, C. R. Bangham, and K. G. Gould. 2002. Presentation of a new H-2D(k)-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin. J. Gen. Virol. 83:641-650.
27. Nasr, R., A. Rosenwald, M. E. El-Sabban, B. Arnulf, P. Zalloua, Y. Lepelletier, F. Bex, O. Hermine, L. Staudt, H. de The, and A. Bazarbachi. 2003. Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells. Blood 101:4576-4582.
28. 27a. Peloponese, J. M., Jr., H. Iha, V. R. K. Yedavalli, Akiko Miyazato, Y. Li, K. Haller, M. Benkirane, and K.-T. Jeang. 2004. Ubiquitination of human T-cell leukemia virus type 1 Tax modulates its activity. J. Virol. 78:11686-11695.
29. Reits, E. A., A. M. Benham, B. Plougastel, J. Neefjes, and J. Trowsdale. 1997. Dynamics of proteasome distribution in living cells. EMBO J. 16:6087-6094.
30. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771.
31. Rousset, R., C. Desbois, F. Bantignies, and P. Jalinot. 1996. Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome. Nature 381:328-331.
32. Slamon, D. J., K. Shimotohno, M. J. Cline, D. W. Golde, and I. S. Chen. 1984. Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-1 and HTLV-1I. Science 226:61-65.
33. Smith, M. R., and W. C. Greene. 1992. Characterization of a novel nuclear localization signal in the HTLV-1 tax transactivator protein. Virology 187: 316-320.
34. Smith, M. R., and W. C. Greene. 1990. Identification of HTLV-1 tax transactivator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 4:1875-1885.
35. Sodroski, J., C. Rosen, W. C. Goh, and W. Haseltine. 1985. A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus. Science 228:1430-1434.
36. Thrower, J. S., L. Hoffman, M. Rechsteiner, and C. M. Pickart. 2000. Recognition of the polyubiquitin proteolytic signal. EMBO J. 19:94-102.
37. Uchiyama, T. 1997. Human T-cell leukemia virus type I (HTLV-1) and human diseases. Annu. Rev. Immunol. 15:15-37.
38. Voges, D., P. Zwickl, and W. Baumeister. 1999. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68:1015-1068.
39. Wilkinson, C. R., M. Seeger, R. Hartmann-Petersen, M. Stone, M. Wallace, C. Semple, and C. Gordon. 2001. Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat. Cell Biol. 3:939-943.
40. Wu, G., G. Xu, B. A. Schulman, P. D. Jeffrey, J. W. Harper, and N. P. Pavletich. 2003. Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase. Mol. Cell 11:1445-1456.
41. Xie, Y., and A. Varshavsky. 2000. Physical association of ubiquitin ligases and the 26S proteasome. Proc. Natl. Acad. Sci. USA 97:2497-2502.